Saturday, January 31, 2026
22.2 C
Bengaluru

Does Public-Private Partnership Benefit The Public?

Does This Public-Private Partnership Benefit The Public?” (Tuesday, July 8, 2025)

Many Indian states, following a Government of India initiative, have handed over public hospitals to private companies under Public-Private Partnership (PPP) models. These reforms aim to improve healthcare quality for low-income patients and reduce government expenditure. However, the article finds that in many cases, neither goal is reliably achieved.

Instead, PPPs risk increasing medical costs, creating access barriers for the poor, and potentially eroding the core principle of universal, free healthcare in government hospitals.

Key Points

✅ Rationale Behind PPPs
• Government hospitals often lack resources, staff, and infrastructure.
• PPPs aim to leverage private expertise and efficiency to improve services without increasing government spending.
• GOI set a target for 50% of hospital beds to be under PPPs.

✅ Concerns Highlighted
• Past PPP models have failed in several Indian states due to higher patient costs and reduced access for poor patients.
• Medical inflation in India (12–14%, highest in Asia) makes PPP healthcare risky for the poor.
• When private players take over public hospitals, free treatment can be replaced by insurance-based or fee-based models, leading to repeated costs for citizens who already funded hospitals via taxes.

✅ Numbers & Data
• Per capita expenditure on health in India remains low.
• Government expenditure on health in 2020-21 was ₹1,815 per person, while private expenditure was ₹4,025 per person, reflecting the burden on households.
• Private sector controls 62% of hospital beds but serves only 52% of hospitalised cases.
• PPP hospitals may prioritise profit over universal access.

✅ Impact on Medical Education
• PPP medical colleges charge high fees, reducing affordability and potentially affecting the supply of affordable doctors.

✅ Key Quote from the Article

“With medical inflation at 12–14% — the highest in Asia — India’s push for PPP healthcare could end up hurting those who can least afford it.”

✅ Broader Implication
• The article questions whether PPPs truly serve public interest or primarily benefit private entities, potentially undermining universal healthcare.

A MedicinManAI Feature

Hot this week

IQVIA vs. PharmaTrac: Indian Pharma Market Data

Here is an analytical blog comparing the IQVIA MFR...

Indian Pharma Market in 2025: Decoding Growth, Therapy Shifts, and the Road Ahead

The latest PharmaTrac report for December 2025 offers a...

Orphan Drugs and Indian Pharma: Moving from Volume to Value?

Zydus’ ZYCUBO May Be the Proof Point the Industry...

Arjun Arunachalam: The Man Who Deleted Helium

For more than fifty years, the MRI industry treated...

Who Is Monitoring Quality in India’s Small Drug Units?

The Telangana Drugs Control Administration’s stop-use notice on a...

Topics

IQVIA vs. PharmaTrac: Indian Pharma Market Data

Here is an analytical blog comparing the IQVIA MFR...

Orphan Drugs and Indian Pharma: Moving from Volume to Value?

Zydus’ ZYCUBO May Be the Proof Point the Industry...

Arjun Arunachalam: The Man Who Deleted Helium

For more than fifty years, the MRI industry treated...

Who Is Monitoring Quality in India’s Small Drug Units?

The Telangana Drugs Control Administration’s stop-use notice on a...

Zydus vs. Helsinn — What It Really Means for Indian Pharma

On December 24, 2025, the Delhi High Court delivered...

Worldclass Healthcare But Out of Reach for Most Indians?

When an eminent cardiologist like Dr. Sunil Chandy—former Director...

Managed Healthcare – Better Choice for India?

Managed care shifts healthcare from fragmented fee-for-service models to...
spot_img

Related Articles

spot_imgspot_img